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Abstract Cdc25C phosphatase induces mitosis by dephosphor-
ylating and activating Cdc2/cyclin B protein kinase. Phosphor-
ylation of Xenopus Cdc25C at serine 287 creates a binding site
for a 14-3-3 protein and restrains activation during interphase.
Here, we show that dephosphorylation of S287 is catalysed by
protein phosphatase-2A in Xenopus egg extracts. 14-3-3 protein
binding to Cdc25C inhibits dephosphorylation of S287, provid-
ing a mechanism to maintain phosphorylation of that site during
interphase. The rate of dephosphorylation of S287 is not in-
creased in mitotic extracts, indicating that the phosphorylation
status of the site is likely to be controlled through modulation of
kinases or 14-3-3 binding activity. * 2002 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The initiation of mitosis in eukaryotic cells is coordinated
by the activation of the cyclin-dependent protein kinase Cdc2/
cyclin B. In addition to association with cyclin B, the Cdc2
catalytic subunit requires correct phosphorylation for activity.
Phosphorylation of a threonine residue in the T-loop (T161 in
vertebrate Cdc2) is essential for activity, but Cdc2 is kept
inactive during interphase by dominant inhibitory phosphor-
ylation at T14 and Y15. The ¢nal activation step of Cdc2 is
the removal of these inhibitory phosphates by the dual-spec-
i¢city protein phosphatase Cdc25 [1].
In vertebrates, Cdc25C is activated at the G2/M transition
by phosphorylation on multiple Ser/Thr residues [2,3] cata-
lysed by the polo-like kinase Plk1/Plx1 [4] and Cdc2/cyclin
B [5], creating a feedback activation loop that causes the rapid
activation of Cdc2 upon entry into mitosis [6]. Studies using
speci¢c inhibitors have shown the enzyme responsible for de-
phosphorylating these activating sites of Cdc25C is a type-2A
protein phosphatase (PP2A), which is speci¢cally repressed in
mitosis [2,7]. Conversely, Cdc25C is phosphorylated during
interphase at an inhibitory site (S287 in Xenopus, S216 in
human), which is critical for determining the length of G2
and for cell cycle arrest induced by checkpoint signals [8^
10]. S287 is the target of Chk1 and Cds1/Chk2 protein ki-
nases, which are activated in response to damaged or unrepli-
cated DNA. Phosphorylation of S287 of Cdc25C directly in-
hibits its catalytic activity [11,12] and creates a mode 1
binding site for 14-3-3 proteins [8,9,13,14] (Fig. 1A), seques-
tering Cdc25C in the cytoplasm [15^19]. In Xenopus egg ex-
tracts, Cdc25C is stoichiometrically bound via phospho-S287
to either the O or j isoform of 14-3-3 during interphase, but
14-3-3 binding is lost in mitosis suggesting that S287 becomes
dephosphorylated [9]. Although not previously described, the
protein phosphatase that acts on S287 may play a role in the
control of phosphorylation at this site and thereby determine
the activity of Cdc25C.
Here, we show that S287 is dephosphorylated in Xenopus
egg extracts by PP2A, the same activity that removes phos-
phate from activating phosphorylation sites on Cdc25C. We
show that binding of a 14-3-3 protein to Cdc25C inhibits the
dephosphorylation of S287 in interphase, indicating that 14-3-
3 may play a role in the maintenance of inhibitory phosphor-
ylation of Cdc25C in interphase and under checkpoint-in-
duced conditions.
2. Materials and methods
2.1. Production of glutathione S-transferase (GST) fusion proteins
A 135 bp section of a Xenopus Cdc25C cDNA [3], encoding amino
acids 271^316, and the 744 bp coding sequence of Xenopus 14-3-3j
[20] were ampli¢ed by PCR and cloned into the pGEX-4T-1 vector
(Amersham Biosciences). Site-directed mutagenesis was carried out
using the QuikChange kit (Stratagene) and con¢rmed by automated
DNA sequencing. GST fusion proteins were expressed in Escherichia
coli BLR (DE3) cells, puri¢ed by a⁄nity chromatography on gluta-
thione^Sepharose 4B (GS4B, Amersham Biosciences) and stored in
10 mM HEPES^KOH, pH 7.5, 1 mM DTT at 370‡C.
2.2. Xenopus egg extracts
Interphase extracts were prepared from Xenopus eggs by the meth-
od of Hutchison [21]. Cystostatic factor (CSF)-arrested, M-phase egg
extracts were prepared by the method of Murray [22]. CSF release
into interphase induced by the addition of 0.8 mM CaCl2 was con-
¢rmed by loss of mitotic spindle morphology [22] and reduction in
Cdc2/cyclin B kinase activity [23]. Cdc2 was activated in interphase
Xenopus egg extract by addition of 2 WM Arbacia punctulata cyclin
Bv90 [24] and incubation at room temperature for 120 min [23].
2.3. Protein kinases, protein phosphatases, inhibitors
GST-tagged human Chk1 (GST^hChk1) was expressed and puri¢ed
as described [25]. The GST moiety was removed using thrombin pro-
tease. Puri¢ed rabbit PP1 catalytic subunit, human PP2A (AC hetero-
dimer), human PP2CK and human inhibitor-2 (I-2) were from Up-
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state. Stock solutions of 500 WM microcystin-LR (MC) and okadaic
acid (OA; Calbiochem) were prepared in DMSO.
2.4. Preparation of 32P-phosphorylated GST^Cdc25C(271^316)
GST^Cdc25C(271^316) protein (200 Wg) was phosphorylated in
100 Wl bu¡er A (20 mM HEPES^KOH, pH 7.5, 150 mM NaCl,
2 mM DTT) plus 10 mM MgCl2, 100 WM [Q-32P]ATP (approx.
37 kBq/nmol), 50 ng Chk1 and 20 Wl (bed volume) GS4B, at room
temperature with rotation for 30 min. The beads were washed in
bu¡er A, then GST^Cdc25C(271^316) protein was eluted in bu¡er
A containing 50 mM glutathione. The eluate was bu¡er-exchanged
(for bu¡er A) and concentrated in an Ultrafree-0.5 centrifugal ¢lter
device (Millipore).
2.5. S287 dephosphorylation assay
Dephosphorylation of [32P-S287]GST^Cdc25C(271^316) protein
(0.1 mg/ml) in interphase Xenopus egg extract was carried out at
room temperature for 30 min, unless indicated otherwise. Diluted
extract (1:100) was prepared in bu¡er A plus 1 mg/ml bovine serum
albumin. For puri¢ed protein phosphatases, 1 U is de¢ned as that
activity which releases 1 nmol phosphate from a phosphoprotein sub-
strate per min. The reaction with PP2C also contained 10 mM MgCl2.
To analyse the loss of radiolabel, samples were separated on a SDS^
12% PAGE gel and analysed by autoradiography.
2.6. Binding of 14-3-3 proteins to Cdc25C
GST^Cdc25C(271^316) protein (50 Wg) was ¢rst phosphorylated in
bu¡er AM (bu¡er A plus 10 mM MgCl2) plus 100 WM ATP and 60 ng
Chk1 for 2 h at 37‡C. 20 Wl of GS4B (50% slurry, in bu¡er AM) was
then added and incubated for 1 h at room temperature with rotation
to bind the GST^Cdc25C(271^316) to the beads. 100 Wl interphase
Xenopus egg extract (diluted 1:10 in bu¡er AM) was added, with 30 ng
Chk1 and 0.1 WM OA where indicated, and incubated for 1 h at room
temperature with agitation. The beads were washed ¢ve times with
200 Wl bu¡er AM plus 1% (v/v) detergent: Nonidet P-40 (Roche),
Triton X-100 (Sigma) or Empigen-BB (a gift from Ellis and Everard
Ltd.), eluted in SDS^PAGE sample bu¡er and analysed by Western
blotting with a rabbit polyclonal anti-14-3-3 antibody that recognises
all isotypes (sc-629, Santa Cruz Biotechnology).
3. Results
3.1. Dephosphorylation of S287 of Cdc25C in Xenopus egg
extracts
To generate a probe to investigate the dephosphorylation of
the S287 residue of Cdc25C, a fragment derived from residues
271^316 of the N-terminal regulatory domain of Xenopus
Cdc25C (Fig. 1A) was expressed as a GST-fusion protein in
E. coli and puri¢ed to near homogeneity. Variant forms of
GST^Cdc25C(271^316) were produced by site-directed muta-
genesis, named according to the amino acid sequence of res-
idues 285^287. When incubated with Mg2þ[Q-32P]ATP and
Chk1 in vitro, the SPS and APS proteins became 32P-phos-
phorylated to a very similar extent, while the SPA or SPD
proteins (which have non-phosphorylatable residues in the
287 position) were not phosphorylated, nor was GST (Fig.
1B), demonstrating that S287 is the exclusive target of Chk1
within GST^Cdc25C(271^316).
When incubated with interphase Xenopus egg extract,
[32P]phosphate was rapidly lost from [32P-S287]SPS protein
(Fig. 1C). The loss of [32P]phosphate was completely blocked
by 1 WM OA, an inhibitor of type-1 or type-2A serine/threo-
nine protein phosphatases [26], demonstrating that interphase
egg extract contains a protein phosphatase which targets
S287-phosphatase (hereafter referred to as the S287-phospha-
tase). Scintillation counting of excised bands from the SDS^
PAGE gel showed that the loss of radiolabel was approxi-
mately linear with respect to time, enabling it to be used as
an assay for S287-phosphatase activity.
3.2. Characterisation of the S287-phosphatase in Xenopus egg
extracts
To characterise biochemically the type of protein phospha-
tase acting on S287, the dephosphorylation of [32P-S287]SPS
protein by dilute egg extract was assayed in the presence of
inhibitors and activators of protein Ser/Thr phosphatases [27]
(Fig. 2). Similar to the e¡ect of 1 WM OA, dephosphorylation
was completely inhibited by 1 WM MC [28] (Fig. 2A), con-
¢rming the involvement of PP1 or PP2A. However, I-2, which
speci¢cally inhibits PP1 [27], had no inhibitory e¡ect on S287
dephosphorylation (Fig. 2B), showing that the predominant
S287-phosphatase activity in Xenopus egg extract is type-2A.
Neither EGTA nor EDTA (which chelate Ca2þ and Mg2þ
required by PP2B and PP2C, respectively) inhibited the
S287-phosphatase, nor were Ca2þ or Mg2þ ions (at 10 mM)
able to stimulate dephosphorylation of S287 in the presence of
1 WM OA (Fig. 2A), con¢rming that PP2B and PP2C do not
make a signi¢cant contribution towards S287-phosphatase ac-
tivity.
Half-maximal inhibition of S287-phosphatase activity in di-
lute interphase egg extract occurred at 4.8 nM OA (Fig. 2C),
consistent with the classi¢cation of this phosphatase as
type-2A [7,27,29]. Indeed, when incubated with 0.1 U of pu-
ri¢ed PP1 (catalytic subunit), PP2A (AC dimer) or PP2C,
[32P-S287]SPS protein was most e⁄ciently dephosphorylated
by PP2A (Fig. 2D).
3.3. Dephosphorylation of S287 by interphase and mitotic egg
extracts
S287 in Xenopus Cdc25C is phosphorylated and bound to a
Fig. 1. Phosphorylation and dephosphorylation of the Ser-287 resi-
due of Xenopus Cdc25C. A: Amino acid sequence and features of
Cdc25C(271^316). B: Phosphorylation of GST^Cdc25C(271^316)
SPS and variants by Chk1, analysed by SDS^PAGE and autora-
diography. GST provided an additional control. C: Dephosphoryla-
tion of [32P-S287]SPS protein in dilute interphase Xenopus egg ex-
tract with (OA) or without (bu¡er) addition of 1 WM OA, analysed
by SDS^PAGE and autoradiography.
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14-3-3 protein during interphase in egg extract [9], but release
of 14-3-3 in M-phase extract [8,9] suggests that S287 is de-
phosphorylated in mitosis, although cell cycle-dependent
changes in the activities of protein kinases or phosphatases
targeting this site have not been reported. One possibility is
that the activity of the S287-phosphatase changes during the
cell cycle, being elevated during mitosis to keep the inhibitory
S287 residue of Cdc25C dephosphorylated. However, we
found that [32P-S287]SPS and -APS proteins were dephos-
phorylated faster in interphase than in the M-phase egg ex-
tract (Fig. 3A), similar to the activating sites on Cdc25C phos-
phorylated by Cdc2/cyclin B [7]. Similarly, the rate of S287
dephosphorylation in an interphase extract was reduced by
addition of cyclin Bv90, which stably activates Cdc2 protein
kinase (Fig. 3B). Thus, a change in S287-phosphatase activity
is unlikely to account for speci¢c dephosphorylation of S287
in mitosis. Interestingly, the APS protein was consistently de-
phosphorylated in egg extract at a faster rate than the SPS
protein (Fig. 3A).
3.4. E¡ect of 14-3-3 protein binding on S287 dephosphorylation
GST^Cdc25C(271^316) SPS protein bound and precipitated
14-3-3 proteins from interphase Xenopus egg extract incubated
with Chk1 and OA (Fig. 4A). However, the APS, SPA or
SPD proteins did not interact with 14-3-3 proteins, demon-
strating the requirement for phosphoserine at residue 287 and
serine at residue 285, consistent with other 14-3-3 binding sites
that require either serine or an aromatic residue at the 32
position [13]. Interaction of 14-3-3 with the SPS protein de-
pended on the detergent present during washing: binding was
detected when the non-ionic detergents Nonidet P-40 and Tri-
ton X-100 were used, but was completely absent with the
zwitterionic detergent Empigen-BB, which disrupts 14-3-3
binding to certain phosphorylation sites [30].
The inability of 14-3-3 to bind the APS protein suggested
an explanation for the more rapid dephosphorylation of this
protein in concentrated egg extracts (Fig. 3A). We tested the
possibility that 14-3-3 binding inhibited S287 dephosphoryla-
tion by adding GST^14-3-3j to extract diluted 1:100 where
the endogenous 14-3-3 concentration (27 nM; [9]) would be
less than that of the exogenous phosphatase substrate. An
excess of GST^14-3-3j (10 or 20 WM) inhibited the dephos-
phorylation of 3 WM [32P-S287]SPS in diluted interphase egg
Fig. 2. Characterisation of the phosphatase activity targeting the
Ser-287 site of Cdc25C. A,B: Dephosphorylation of [32P-S287]SPS
protein in dilute egg extract plus the stated compounds (OA or MC
at 1 WM; EGTA, EDTA, CaCl2 or MgCl2 at 10 mM) or I-2. C: In-
hibition of [32P-S287]SPS dephosphorylation in dilute egg extract by
OA. Following SDS^PAGE and autoradiography, bands were scin-
tillation counted to determine the amount of phosphate remaining
in the substrate. D: Dephosphorylation of [32P-S287]SPS protein by
dilute egg extract or 0.1 U of puri¢ed protein phosphatase.
Fig. 3. Rate of S287 dephosphorylation in interphase and mitotic
Xenopus egg extracts. A: Dephosphorylation of [32P-S287]SPS or
-APS protein (400 Wg/ml) in a concentrated CSF-arrested egg extract
which had previously been incubated for 40 min with either 0.8 mM
CaCl2 (interphase, I) or bu¡er (M-phase, M). B: Dephosphorylation
of [32P-S287]SPS protein (400 Wg/ml) in a concentrated interphase
egg extract which had previously been incubated with bu¡er or cy-
clin Bv90 to activate Cdc2 protein kinase.
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extract (Fig. 4B). However, under conditions where SPS de-
phosphorylation was inhibited by GST^14-3-3j, the APS pro-
tein was dephosphorylated (Fig. 4C). Removal of phosphate
from S287 catalysed by puri¢ed PP2A was also completely
inhibited by GST^14-3-3j (Fig. 4D). Taken together, these
data indicate that binding of 14-3-3 to Cdc25C via the
S287-phosphatase motif inhibits the dephosphorylation of
this residue.
4. Discussion
In this study we have investigated the dephosphorylation of
the inhibitory S287 residue of Cdc25C. The protein phospha-
tase that acts on this site in Xenopus egg extracts is classi¢ed
as type-2A, the same as the phosphatase that dephosphory-
lates activating phosphorylation sites on Cdc25C. This creates
a paradox in understanding how the phosphorylation of these
sites may be di¡erentially regulated. However, dephosphory-
lation of S287 is inhibited by 14-3-3, a protein which forms a
stable interaction with the phosphorylation site during inter-
phase, maintaining the stable phosphorylation of this site dur-
ing interphase when PP2A activity towards Cdc25C is high
and the activating sites are kept dephosphorylated.
Phosphatase activity towards S287 on Cdc25C may play an
important role in overcoming G2 timing controls and check-
point restraint of mitosis in response to DNA damage or
replication arrest. A reduction in S287-phosphatase and loss
of 14-3-3 binding to Cdc25C in mitosis [8,9] indicates that the
balance between kinase and phosphatase activities acting on
this site switches at the G2/M transition. However, we found
that the rate of S287 dephosphorylation is not increased in
mitotic extracts compared to interphase extracts, indicating
that net dephosphorylation and loss of 14-3-3 binding to
Cdc25C in mitosis are not a consequence of elevated PP2A
activity towards that site. Rather it seems that PP2A activity
towards both inhibitory (this report) and activating sites [7]
on Cdc25C is decreased during mitosis, either due to compe-
tition from the increased abundance of phosphoproteins dur-
ing mitosis [31] or a more speci¢c down-regulation of PP2A
activity towards Cdc25C [7]. Net dephosphorylation of S287
in mitosis may therefore be a consequence of inactivation of
the relevant kinase activities, assuming that the interaction
between 14-3-3 and the phosphorylated binding site is dynam-
ic. Another possibility is that 14-3-3 itself becomes modi¢ed,
e.g. by phosphorylation [32,33], reducing its binding activity
and causing dissociation from Cdc25C.
14-3-3 proteins are members of a functional group of sig-
nalling molecules which bind proteins containing phosphory-
lated residues, usually within a particular sequence context
[34] ; these include Src-homology 2 domains [35], forkhead-
associated (FHA) domains [36], and certain WW domains
[37]. Like the e¡ect on Cdc25C S287 dephosphorylation,
14-3-3 proteins can inhibit dephosphorylation of binding part-
ners such as histones [38], tyrosine and tryptophan hydroxy-
lases [39,40], and the Ser/Thr kinase Raf-1 [30,41,42]. Simi-
larly, the FHA1 domain of Rad53p inhibits dephosphoryla-
tion of the pThr18 residue of human p53 to which it binds
[36]. Crystal structures of a 14-3-3 dimer [13,43], FHA do-
mains and WW domains bound to phosphorylated peptides
[44^46] provide an explanation for these e¡ects: the side-
chains of the phosphoserine or phosphothreonine residues
are buried within speci¢city pockets in these binding domains
and protein phosphatases would be unable to gain access. In
the physiological context, the dynamics of the interaction be-
tween the phosphoprotein and its binding partner are likely to
determine the e¡ect on phosphorylation status. One function
of proteins that bind to phosphorylated epitopes may be to
control the persistence of phosphorylation at particular sites
after the temporal decline of kinase activity or spatial separa-
tion of a phosphoprotein from the kinase within a cell. In the
case of Cdc25C, 14-3-3 binding also determines cellular local-
Fig. 4. E¡ect of 14-3-3 protein binding on S287 dephosphorylation.
A: Binding of 14-3-3 from interphase Xenopus egg extract to immo-
bilised GST^Cdc25C(271^316) proteins (SPS or mutants, as indi-
cated) in the presence or absence of Chk1 and OA, and the indi-
cated detergent (TX, Triton X-100; Emp, Empigen BB). The
leftmost lane (XEE) represents 1 Wl of egg extract. B: E¡ect of
14-3-3j on dephosphorylation of [32P-S287]SPS protein (3 WM) incu-
bated for the times indicated with dilute egg extract. C: Dephos-
phorylation of [32P-S287]SPS or -APS protein (5 WM) incubated
with dilute egg extract in the presence of GST or GST^14-3-3j (50
WM). D: Dephosphorylation of [32P-S287]SPS protein (50 Wg/ml) in-
cubated with 0.02 U puri¢ed PP2A and 14-3-3j (500 Wg/ml) as indi-
cated.
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isation of the phosphoprotein, since a nuclear localisation
signal on Cdc25C is masked by 14-3-3 binding and Cdc25C
is excluded from the nucleus by active export [18].
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